Moringa

Moringa oleifera
Evidence Level
Limited
2 Clinical Trials
4 Documented Benefits
2/5 Evidence Score

Moringa (Moringa oleifera) is a fast-growing tree whose leaves are dried into a nutrient-dense green powder rich in vitamins A and C, calcium, iron, protein, and antioxidants. It is used as a whole-food nutritional boost and has been studied for blood sugar, cholesterol and inflammation, with mixed results so far. Commonly added to smoothies and foods at about 1 to 2 teaspoons per day, moringa leaf is generally very safe and well tolerated. The root and root bark, however, contain compounds that should be avoided, especially during pregnancy. Because it may lower blood sugar and blood pressure, those on related medications should monitor their levels.

Studied Dose 2–7 g/day leaf powder; trials have used about 2.4 to 8 g/day of leaf powder, and one single-meal study used 20 g
Active Compound Isothiocyanates (moringin, glucomoringin), quercetin, chlorogenic acid — leaf extract

Benefits

Antioxidant support, with mixed human results

Moringa leaves contain quercetin, kaempferol, chlorogenic acid and isothiocyanates. In one 3-month controlled study, 30 postmenopausal women taking 7 g a day of leaf powder ended with higher superoxide dismutase and glutathione peroxidase activity and lower malondialdehyde than they started with, alongside a non-supplemented comparison group, but the study was small and not blinded. In a double-blind placebo-controlled trial in adults with prediabetes, plasma antioxidant capacity, C-reactive protein and interleukin-6 did not differ from placebo, so the picture is mixed rather than settled.

Blood sugar support, with mixed trial results

Results are mixed. In a 12-week double-blind trial in adults with prediabetes, 2400 mg a day of leaf powder moved fasting glucose and HbA1c in a favorable direction compared with placebo. A single 20 g dose taken with a meal lowered the overall glucose response in people with type 2 diabetes, while the healthy subjects in that same study showed no difference. Two randomized trials in people with type 2 diabetes found no significant difference in fasting glucose compared with control. Laboratory work suggests isothiocyanates and chlorogenic acid slow carbohydrate digestion.

Cholesterol reduction

Lipid results are inconsistent. A 2025 meta-analysis of nine randomized trials found no significant effect of moringa on total cholesterol, LDL, HDL or triglycerides, with very low certainty of evidence, and one trial in people with type 2 diabetes reported a rise rather than a fall in triglycerides in one dose group. Beta-sitosterol in the leaf is a plausible reason some studies see a benefit, but the human data do not line up yet, and the amount of plant sterol in a normal serving is small.

Nutritional density

These familiar comparisons come from weighing dried leaf powder against fresh foods, so they are not like for like. Dried moringa leaf powder is genuinely dense in calcium, iron, protein and vitamin A precursors, but a realistic serving of 1 to 2 teaspoons is only about 2 to 6 grams, so what it actually adds to a day is modest. Treat it as a green food that tops up nutrients, not as a replacement for milk, spinach or eggs.

Mechanism of action

1

Isothiocyanate antioxidant activation

Moringin activates the Nrf2 transcription factor, inducing phase II detoxification enzymes (GST, NQO1, HO-1) and antioxidant response element genes. This is cell and animal work, not a measured effect in people.

2

Alpha-glucosidase inhibition

In laboratory tests, moringa isothiocyanates and phenolic acids inhibit carbohydrate-digesting enzymes such as alpha-amylase and alpha-glucosidase, the intestinal enzyme responsible for breaking down complex carbohydrates into glucose, slowing glucose absorption.

3

Phytosterol-mediated cholesterol reduction

Beta-sitosterol and other plant sterols in moringa compete with cholesterol for intestinal absorption, reducing net cholesterol uptake. The sterol content of an ordinary serving of leaf powder is small, and human trials have not shown a consistent change in cholesterol.

Clinical trials

1
Moringa Leaf Powder in Prediabetes: Randomized Placebo-Controlled Trial

Double-blind, randomized, placebo-controlled trial of 2400 mg a day of dried leaf powder capsules for 12 weeks. (Gomez-Martinez et al. 2021, Nutrients 14(1):57, PMID 35010932)

65 adults with prediabetes, 31 on moringa and 34 on placebo. 12-week intervention.

Fasting blood glucose and HbA1c moved in opposite directions between the groups, falling in the moringa group and rising in the placebo group, which the authors read as a favorable glycemic effect. Gut microbiota, appetite-controlling hormones and liver and kidney markers did not differ between groups. A companion analysis of the same trial found no difference from placebo in blood pressure, blood lipids, plasma antioxidant capacity, C-reactive protein or interleukin-6. This is one small trial, and moringa is not a treatment for diabetes or prediabetes.

2
Moringa and Oxidative Stress Markers in Postmenopausal Women

Controlled supplementation study in 90 postmenopausal women in three groups of 30: 7 g a day of moringa leaf powder, 9 g a day of amaranth leaf powder, or no supplement, for 3 months. Outcomes: superoxide dismutase, glutathione peroxidase, malondialdehyde, serum retinol and ascorbic acid, and fasting blood glucose. (Kushwaha et al. 2014, J Food Sci Technol 51(11):3464-9, PMID 26396347)

90 postmenopausal women aged 45 to 60, of whom 30 took moringa leaf powder. 3-month intervention.

In the moringa group superoxide dismutase rose about 10 percent, glutathione peroxidase about 18 percent and serum ascorbic acid about 44 percent, while malondialdehyde, a marker of lipid oxidation, fell about 16 percent and fasting blood glucose fell about 13.5 percent. These were changes from each group's own starting values, with a non-supplemented comparison group. Inflammatory markers such as CRP and IL-6 were not measured in this study. It was small, was not blinded, and used an unsupplemented rather than a placebo control, so treat it as preliminary.

Side effects and drug interactions

Common Potential side effects

Generally well tolerated at leaf powder doses up to 8 g/day
GI discomfort and diarrhea at higher doses
Root and bark extracts contain different compounds and should be avoided; leaf powder is the form used in studies. Pregnancy and breastfeeding: leaf is eaten as a food in many countries, but concentrated supplement doses have not been studied in pregnancy, so ask a doctor first

Important Drug interactions

Antidiabetic medications — additive glucose-lowering; monitor blood sugar
Levothyroxine — may reduce thyroid hormone absorption; separate by 4 hours
Anticoagulants — moringa contains vitamin K; monitor with warfarin

Frequently asked questions about Moringa

What is moringa used for?

Moringa (Moringa oleifera) is a nutrient-dense tree whose leaves are used as a green superfood, rich in vitamins, minerals, protein, and antioxidants. It is used for general nutrition, energy, and antioxidant and metabolic support.

What is moringa good for?

It is valued as a whole-food source of vitamins A and C, calcium, iron and antioxidants, and has been studied for blood sugar, cholesterol and inflammation, though trial results are mixed. It is popular as a daily green nutritional boost.

How much moringa should I take?

Moringa leaf powder is commonly used at about 1 to 2 teaspoons (roughly 2 to 6 grams) per day in smoothies or food; follow product labeling. The leaves are also eaten as a vegetable.

Is moringa safe?

Moringa leaf is generally very safe and nutritious. The root and root bark contain compounds that should be avoided, especially in pregnancy. Because it may lower blood sugar and blood pressure, those on related medications should monitor.

What is Moringa?

Moringa (Moringa oleifera) is a fast-growing tree whose leaves are dried into a nutrient-dense green powder rich in vitamins A and C, calcium, iron, protein, and antioxidants. It is used as a whole-food nutritional boost and has been studied for blood sugar, cholesterol and inflammation, with mixed results so far.

What is the recommended dosage of Moringa?

The clinically studied dose is 2–7 g/day leaf powder; trials have used about 2.4 to 8 g/day of leaf powder, and one single-meal study used 20 g Always follow the product label and check with a healthcare provider for personal advice.

Is Moringa safe, and does it have side effects?

For most healthy adults, Moringa is well tolerated at studied doses. Reported effects can include: Generally well tolerated at leaf powder doses up to 8 g/day GI discomfort and diarrhea at higher doses It may also interact with some medications. Moringa is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Moringa interact with any medications?

Possible interactions include: Antidiabetic medications — additive glucose-lowering; monitor blood sugar Levothyroxine — may reduce thyroid hormone absorption; separate by 4 hours If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Moringa?

NutraSmarts rates the evidence for Moringa as Limited (2 out of 5). It is backed by 2 clinical trials and 7 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(7 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Gómez-Martínez S, Díaz-Prieto LE, Vicente Castro I, Jurado C, Iturmendi N, Martín-Ridaura MC, Calle N, Dueñas M, Picón MJ, Marcos A, Nova E. Moringa oleifera Leaf Supplementation as a Glycemic Control Strategy in Subjects with Prediabetes. Nutrients. 2021;14(1):. doi: 10.3390/nu14010057.PubMedUsed to support: Double-blind placebo-controlled trial, 2400 mg a day for 12 weeks in 65 adults with prediabetes: fasting blood glucose and HbA1c changed in opposite directions between the groups, improving with moringa and worsening with placebo. Microbiota, appetite-controlling hormones and liver and kidney markers were unchanged. Supports a modest blood-sugar effect in prediabetes and nothing wider.
  2. Leone A, Bertoli S, Di Lello S, Bassoli A, Ravasenghi S, Borgonovo G, Forlani F, Battezzati A. Effect of Moringa oleifera Leaf Powder on Postprandial Blood Glucose Response: In Vivo Study on Saharawi People Living in Refugee Camps. Nutrients. 2018;10(10):. doi: 10.3390/nu10101494.PubMedUsed to support: Single-meal study in Saharawi refugee camps: 20 g of leaf powder eaten with a meal lowered the overall glucose response in 17 people with type 2 diabetes, with the peak arriving earlier and smaller rises at 90 to 150 minutes, while the 10 healthy subjects showed no differences. Backs a postprandial effect in diabetes only, and the authors noted the 20 g meal had poor taste acceptability.
  3. Taweerutchana R, Lumlerdkij N, Vannasaeng S, Akarasereenont P, Sriwijitkamol A. Effect of Moringa oleifera Leaf Capsules on Glycemic Control in Therapy-Naïve Type 2 Diabetes Patients: A Randomized Placebo Controlled Study. Evid Based Complement Alternat Med. 2017;2017:6581390. doi: 10.1155/2017/6581390.PubMedUsed to support: Randomized placebo-controlled study, 8 g a day of leaf capsules for 4 weeks in 32 people with therapy-naive type 2 diabetes: there was no significant difference in fasting plasma glucose or HbA1c between groups, and the authors concluded moringa leaf had no effect on glycemic control. Systolic blood pressure was about 5 mmHg lower than baseline but the change was not statistically significant. Listed here as a null result for balance.
  4. Crișan D, Gavrilaș L, Păltinean R, Frumuzachi O, Mocan A, Crișan G. Effects of Moringa oleifera Lam. Supplementation on Cardiometabolic Outcomes: A Meta-Analysis of Randomized Controlled Trials with GRADE Assessment. Nutrients. 2025;17(22):. doi: 10.3390/nu17223501.PubMedUsed to support: Meta-analysis of nine randomized trials with GRADE assessment, 341 supplemented and 308 control participants: moringa showed no significant effect on most cardiometabolic outcomes. Only a modest reduction in diastolic blood pressure reached significance, and it did not hold up in sensitivity analysis. Heterogeneity was high and certainty of evidence was rated very low for every outcome. The most complete synthesis available, and it concludes current evidence does not support consistent cardiometabolic benefit.
  5. C Afiaenyi I, K Ngwu E, M Okafor A, Ayogu RN. Effects of Moringa oleifera leaves on the blood glucose, blood pressure, and lipid profile of type 2 diabetic subjects: A parallel group randomized clinical trial of efficacy. Nutr Health. 2025;31(1):281-291. doi: 10.1177/02601060231176873.PubMedUsed to support: Randomized trial of 20, 40 or 60 g of moringa leaves daily for 14 days in 40 Nigerian adults with type 2 diabetes: mean fasting blood glucose did not differ between groups, one dose group had a significant increase in triglycerides, and after adjusting for pre-intervention values no parameter differed significantly. The authors described the changes as marginal and not dose-dependent.
  6. Kushwaha S, Chawla P, Kochhar A Effect of supplementation of drumstick (Moringa oleifera) and amaranth (Amaranthus tricolor) leaves powder on antioxidant profile and oxidative status among postmenopausal women. J Food Sci Technol. 2014;51(11):3464-9..PubMedUsed to support: Controlled supplementation study in 90 postmenopausal women aged 45 to 60, in three groups of 30. The moringa group took 7 g a day of leaf powder for 3 months and ended with higher superoxide dismutase and glutathione peroxidase activity, higher serum retinol and ascorbic acid, lower malondialdehyde and lower fasting blood glucose than at the start, against a non-supplemented comparison group. It was small and not blinded, so treat it as preliminary. This is the study described in the postmenopausal trial card and the only human antioxidant-outcome evidence the page has.
  7. Díaz-Prieto LE, Gómez-Martínez S, Vicente-Castro I, et al. Effects of Moringa oleifera Lam. Supplementation on Inflammatory and Cardiometabolic Markers in Subjects with Prediabetes. Nutrients. 2022;14(9)..PubMedUsed to support: Ancillary analysis of the same 12-week prediabetes trial as PMID 35010932, in the same 65 participants taking 2400 mg a day of dry leaf powder or placebo. Moringa did not differ from placebo in C-reactive protein, interleukin-6, TNF-alpha, fecal inflammatory markers, serum lipid profile, blood pressure or plasma antioxidant capacity. Included for balance, and it is the reason the page no longer claims reductions in inflammatory markers or cholesterol.